HomeCompareBCCOY vs DIVO

BCCOY vs DIVO: Dividend Comparison 2026

BCCOY yields 533.33% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCCOY wins by $101500.19M in total portfolio value
10 years
BCCOY
BCCOY
● Live price
533.33%
Share price
$0.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$101500.22M
Annual income
$74,150,491,507.64
Full BCCOY calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — BCCOY vs DIVO

📍 BCCOY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCCOYDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCCOY + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BCCOY pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCCOY
Annual income on $10K today (after 15% tax)
$45,333.33/yr
After 10yr DRIP, annual income (after tax)
$63,027,917,781.49/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, BCCOY beats the other by $63,027,916,947.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCCOY + DIVO for your $10,000?

BCCOY: 50%DIVO: 50%
100% DIVO50/50100% BCCOY
Portfolio after 10yr
$50750.13M
Annual income
$37,075,246,244.66/yr
Blended yield
73.05%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCCOY buys
0
DIVO buys
0
No recent congressional trades found for BCCOY or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCCOYDIVO
Forward yield533.33%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$101500.22M$30.7K
Annual income after 10y$74,150,491,507.64$981.68
Total dividends collected$99158.23M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BCCOY vs DIVO ($10,000, DRIP)

YearBCCOY PortfolioBCCOY Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$64,033$53,333.33$11,349$649.42+$52.7KBCCOY
2$387,685$319,169.26$12,833$688.83+$374.9KBCCOY
3$2,220,791$1,805,968.17$14,459$727.90+$2.21MBCCOY
4$12,044,657$9,668,410.74$16,238$766.49+$12.03MBCCOY
5$61,894,777$49,006,993.47$18,179$804.47+$61.88MBCCOY
6$301,588,053$235,360,641.70$20,293$841.71+$301.57MBCCOY
7$1,394,490,436$1,071,791,219.76$22,591$878.14+$1394.47MBCCOY
8$6,123,670,416$4,631,565,648.90$25,087$913.65+$6123.65MBCCOY
9$25,560,497,666$19,008,170,321.16$27,791$948.18+$25560.47MBCCOY
10$101,500,224,010$74,150,491,507.64$30,718$981.68+$101500.19MBCCOY

BCCOY vs DIVO: Complete Analysis 2026

BCCOYStock

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.

Full BCCOY Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this BCCOY vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCCOY vs SCHDBCCOY vs JEPIBCCOY vs OBCCOY vs KOBCCOY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.